Fusion Antibodies (FAB) Stock Chart & Stock Price History GBX 4.25 +0.05 (+1.19%) (As of 11/22/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider Trades Fusion Antibodies Stock Price Performance 5 Day Performance+0.05%1 Month Performance+3.94%3 Month Performance+26.87%6 Month Performance+11.84%Year-To-Date Performance0.00%1 Year Performance+28.79% Receive FAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter. Email Address Popular Stocks at Risk Under Trump—Are You Holding These? (Ad)The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely to lose big time now that Donald Trump has been re-electedClaim your copy before they move FAB Stock Chart for Sunday, November, 24, 2024 FAB Chart by TradingView Fusion Antibodies Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/22/2024GBX 4.20GBX 4.40+4.67%GBX 4.40GBX 4.10304,519 shs£4.19 million11/21/2024GBX 4.39GBX 4.20-4.33%GBX 4.40GBX 4.10410,557 shs£4.01 million11/20/2024GBX 4.25GBX 4.39+3.34%GBX 4.39GBX 4.10384,577 shs£4.19 million11/19/2024GBX 4.66GBX 4.25-8.90%GBX 4.70GBX 4.151.23 million shs£4.05 million11/18/2024GBX 4.30GBX 4.66+8.44%GBX 4.79GBX 4.30870,439 shs£4.45 million11/15/2024GBX 4.20GBX 4.40+4.76%GBX 4.40GBX 4.11148,421 shs£4.20 million Get the Latest News and Ratings for FAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024GBX 4.09GBX 4.20+2.69%GBX 4.20GBX 3.90556,025 shs£4.01 million11/13/2024GBX 4.18GBX 4.09-2.15%GBX 4.18GBX 3.90618,182 shs£3.90 million11/12/2024N/AGBX 4.18GBX 4.30GBX 3.90347,209 shs£3.99 million11/08/2024GBX 4.10GBX 4.05-1.22%GBX 4.30GBX 4.03835,332 shs£3.86 million11/07/2024GBX 4.22GBX 4.10-2.84%GBX 4.29GBX 3.90457,418 shs£3.91 million11/06/2024GBX 4.31GBX 4.22-2.09%GBX 4.31GBX 4.10288,570 shs£4.03 million11/05/2024GBX 4.31GBX 4.31GBX 4.31GBX 4.2595 shs£4.11 million11/04/2024GBX 4.20GBX 4.31+2.62%GBX 4.40GBX 4.10135,138 shs£4.11 million11/01/2024GBX 4.20GBX 4.30+2.38%GBX 4.36GBX 4.08322,002 shs£4.10 million10/31/2024GBX 4.20GBX 4.20GBX 4.40GBX 4.20345,776 shs£4.01 million10/30/2024GBX 4.10GBX 4.20+2.44%GBX 4.40GBX 41.66 million shs£4.01 million10/29/2024GBX 4.32GBX 4.10-5.14%GBX 4.37GBX 4.101.55 million shs£3.91 million10/28/2024GBX 4.10GBX 4.32+5.41%GBX 4.38GBX 4.022.11 million shs£4.12 million10/25/2024GBX 4.09GBX 4.19+2.47%GBX 4.27GBX 3.931.15 million shs£4.00 million10/24/2024GBX 4.07GBX 4.09+0.47%GBX 4.09GBX 3.90363,279 shs£3.90 million10/23/2024GBX 4GBX 4.07+1.75%GBX 4.10GBX 3.90206,955 shs£3.88 million Related Companies NetScientific Stock Price Chart OptiBiotix Health Stock Price Chart Oncimmune Stock Price Chart Synairgen Stock Price Chart BiVictriX Therapeutics Stock Price Chart Cizzle Biotechnology Stock Price Chart ImmuPharma Stock Price Chart Genflow Biosciences Stock Price Chart IXICO Stock Price Chart Aptamer Group Stock Price Chart Receive FAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter. This page (LON:FAB) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredThe #1 ETF for monthly incomeWe just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could...Investors Alley | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Antibodies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.